C Fuchs, S Wauschkuhn, C Scheer, M Vollmer, K Meissner, S-O Kuhn, K Hahnenkamp, A Morelli, M Gründling, S Rehberg
Background: There is growing evidence that beta-blockade may reduce mortality in selected patients with sepsis. However, it is unclear if a pre-existing, chronic oral beta-blocker therapy should be continued or discontinued during the acute phase of severe sepsis and septic shock. Methods: The present secondary analysis of a prospective observational single centre trial compared patient and treatment characteristics, length of stay and mortality rates between adult patients with severe sepsis or septic shock, in whom chronic beta-blocker therapy was continued or discontinued, respectively...
October 1, 2017: British Journal of Anaesthesia